Evelyn Mary McKeegan
Evelyn Mary McKeegan publishes mostly in Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, on topics such as Angiogenesis and VEGF in Cancer, PARP inhibition in cancer therapy and Lung Cancer Treatments and Mutations.
- World rank
- #1,022,319 of 7,710,434 ranked researchers
- Rank in United States
- #333,032 of 1,627,098
- Works
- 63
- Citations
- 4.5k
- Citations per work
- 71.6
What does Evelyn Mary McKeegan research?
Evelyn Mary McKeegan's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (27%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3149.1%
- Medicine3149.1%
- Life Sciences1727.3%
- Everything else1523.6%
- 1Molecular Biology22% of their works
- 2Oncology20% of their works
- 3Pulmonary and Respiratory Medicine12% of their works
- 4Hematology10% of their works
- 5Genetics8% of their works
- 6Cancer Research6% of their works
Research topics
Which keywords describe Evelyn Mary McKeegan's research?
The keywords of their largest research topics: Prognostic Factors, Clinical Trials, Targeted Therapy, Cancer Therapy, Cell Death, Immunotherapy, endothelial progenitor cells and VEGF.
- Genomic Aberrations
- Temozolomide
- Bcl-2 Family
- Acute Myeloid Leukemia
- Small-Cell Lung Cancer
- PARP Inhibitors
- BRCA Mutation
- endothelial progenitor cells
- Immunotherapy
- Cancer Therapy
- Clinical Trials
- Prognostic Factors
- Targeted Therapy
- Cell Death
- VEGF
- ALK Inhibitors
- EGFR Mutations
- Genomic Profiles
- AML
- Apoptosis
- Glioblastoma
- Chronic Lymphocytic Leukemia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Prognostic Factors203 topics
- Clinical Trials172 topics
- Targeted Therapy172 topics
- Cancer Therapy152 topics
- Cell Death152 topics
- Immunotherapy142 topics
- VEGF101 topic
- endothelial progenitor cells101 topic
- ALK Inhibitors91 topic
- BRCA Mutation91 topic
- EGFR Mutations91 topic
- PARP Inhibitors91 topic
- Genomic Profiles81 topic
- Small-Cell Lung Cancer81 topic
- AML71 topic
- Acute Myeloid Leukemia71 topic
- Apoptosis61 topic
- Bcl-2 Family61 topic
- Glioblastoma61 topic
- Temozolomide61 topic
- Chronic Lymphocytic Leukemia51 topic
- Genomic Aberrations51 topic
Where does Evelyn Mary McKeegan work?
Evelyn Mary McKeegan's main affiliation in the publication record is Abbott Fund, United States.
How many publications and citations does Evelyn Mary McKeegan have?
OpenAlex counts 63 works and 4,512 citations for Evelyn Mary McKeegan, an h-index of 23, ranking #1,022,319 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Evelyn Mary McKeegan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.